Medindia
Medindia LOGIN REGISTER
Advertisement

Webcast Alert: Transgenomic Inc. Announces Fourth Quarter 2007 Earnings Release Conference Call Webcast

Saturday, February 23, 2008 General News
Advertisement
OMAHA, Neb., Feb. 22 Transgenomic Inc.(OTC Bulletin Board: TBIO) announces the following Webcast:

To access the call via telephone, call 800-895-1085 or 785-424-1055. Areplay of the call will be available via telephone until 11:59 pm ET onThursday, March 13, 2008. To access, dial 800-723-6062 or 402-220-2665.
Advertisement

About Transgenomic:

Transgenomic is a global biotechnology company that provides uniqueproducts and services for automated high sensitivity genetic variation andmutation analysis. Their offerings include systems, products, discovery andlaboratory testing services to the academic and medical research, clinicallaboratory and pharmaceutical markets in the fields of pharmacogenomics andpersonalized medicine. Specific offerings include WAVE(R) DHPLC Systems,related consumables and assay kits, cytogenetics automated systems,Transgenomic Molecular Clinical Reference Laboratory and PharmacogenomicsResearch Services. Transgenomic's two laboratory services divisions utilizethese technologies and expertise to provide a menu of mutation scanning testsfor over 700 cancer-associated genes and more than 60 validated diagnostictests to meet the needs of pharmaceutical and biotech companies, research andclinical laboratories, physicians and patients. For more information about theinnovative systems, products and services offered by Transgenomic, pleasevisit: http://www.transgenomic.com.What: Transgenomic Inc. Fourth Quarter 2007 Earnings Release Conference Call When: Thursday, February 28, 2008 @ 5:00 p.m. Eastern Where: http://www.transgenomic.com/events.asp?id=6 How: Live over the Internet -- Simply log on to the web at the address above.

SOURCE Transgenomic Inc.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close